Judith S. Greengard

1.2k citations

26 papers · 976 indexed · h-index 18

Co-authors: John H. Griffin Kenneth A. Bauer Mary J. Heeb Sabine Eichinger Lindsey A. Miles Cindy L. Fisher Jonathan B. Rosenberg Robert R. Montgomery
Topics: Blood Coagulation and Thrombosis Mechanisms (12 papers)Virus-based gene therapy research (7 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers)
Cited by: Hematology Genetics Internal Medicine
Journals: New England Journal of Medicine Journal of Biological Chemistry Blood
Partner nations: United States Netherlands Canada

In The Last Decade

Judith S. Greengard

26 papers receiving 930 citations

Peers

Countries citing papers authored by Judith S. Greengard

Since Specialization

Citations

This map shows the geographic impact of Judith S. Greengard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith S. Greengard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith S. Greengard more than expected).

Fields of papers citing papers by Judith S. Greengard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith S. Greengard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith S. Greengard. The network helps show where Judith S. Greengard may publish in the future.

Co-authorship network of co-authors of Judith S. Greengard

This figure shows the co-authorship network connecting the top 25 collaborators of Judith S. Greengard. A scholar is included among the top collaborators of Judith S. Greengard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith S. Greengard. Judith S. Greengard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema 2021 ·Journal of Ocular Pharmacology and Therapeutics ·Claire M. Gelfman,Ruslan N. Grishanin,Kristina Oresic Bender,(unknown),Judith S. Greengard,Pallavi Sharma,(unknown),Szilárd Kiss,Mehdi Gasmi	37
2	Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates 2021 ·Translational Vision Science & Technology ·Szilárd Kiss,Kristina Oresic Bender,Ruslan N. Grishanin,(unknown),(unknown),(unknown),(unknown),(unknown),Judith S. Greengard,Claire M. Gelfman,Mehdi Gasmi	26
3	Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD 2020 ·Molecular Therapy — Methods & Clinical Development ·Szilárd Kiss,Ruslan N. Grishanin,(unknown),(unknown),Judith S. Greengard,(unknown),Claire M. Gelfman,Mehdi Gasmi	23
4	Immunological response and durability of expression following sequential intravitreal administration of AAV2.7m8 gene therapy to the contralateral eye in non-human primates 2019 ·Investigative Ophthalmology & Visual Science ·Diana Cepeda,Edward T.H. Yeh,(unknown),(unknown),Awilda M. Rosario,Judith S. Greengard,Claire M. Gelfman,Mehdi Gasmi	2
5	Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration 2018 ·Molecular Therapy ·Ruslan N. Grishanin,Brian R. Vuillemenot,Pallavi Sharma,Annahita Keravala,Judith S. Greengard,Claire M. Gelfman,(unknown),Matthew S. Lawrence,Wenzheng Hu,Szilárd Kiss,Mehdi Gasmi	94
6	Development of an Optimized rAAV2/6 Human Factor 8 cDNA Vector Cassette for Hemophilia a Gene Therapy 2016 ·Blood ·Brigit E. Riley,(unknown),(unknown),Dominique Cartier,(unknown),Kate Nesbitt,(unknown),Stephen J. Ballaron,(unknown),(unknown),(unknown),Lei Zhang,Kathleen Meyer,Judith S. Greengard,Christine Hough,Richard Surosky,Dale Ando,David Lillicrap,Geoff Nichol,Michael C. Holmes	1
7	ZFN-Mediated Gene Targeting at the Albumin Locus in Liver Results in Therapeutic Levels of Human FIX in Mice and Non-Human Primates 2015 ·Blood ·Thomas Wechsler,Kathleen Meyer,S. Kaye Spratt,Judith S. Greengard,Yolanda Santiago,Scott Sproul,Richard Surosky,David E. Paschon,(unknown),Dale Ando,Geoff Nichol,Edward J. Rebar,Michael C. Holmes	3
8	Engineering Goals for Future Thoracic Endografts—How Can We Make Them More Effective? 2013 ·Progress in Cardiovascular Diseases ·(unknown),(unknown),(unknown),Kevin Boyle,Judith S. Greengard,(unknown),Richard Thomas,Simona Zannetti	14
9	Factors Affecting Long-Term Expression of a Secreted Transgene Product after Intravenous Administration of a Retroviral Vector 2001 ·Molecular Therapy ·James E. McCormack,Wilson B. Edwards,(unknown),(unknown),(unknown),Duane Brumm,Linda M. Karavodin,Douglas J. Jolly,Judith S. Greengard	21
10	Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High Titer 2000 ·Molecular Therapy ·Philip L. Sheridan,Mordechai Bodner,(unknown),(unknown),Nicholas J. DePolo,(unknown),(unknown),Kathy Nguyen,James E. McCormack,David A. Driver,Kay Townsend,Carlos E. Ibañez,Nancy Sajjadi,Judith S. Greengard,Margaret Moore,James Respess,Stephen M. W. Chang,Thomas W. Dubensky,Douglas J. Jolly,Sybille L. Sauter	49
11	Analysis of Testes and Semen from Rabbits Treated by Intravenous Injection with a Retroviral Vector Encoding the Human Factor VIII Gene: No Evidence of Germ Line Transduction 2000 ·Human Gene Therapy ·Holger Roehl,(unknown),Judith S. Greengard,(unknown),William G. Glass,Martin Giedlin,Kim Boekelheide,Dale E. Johnson,Douglas J. Jolly,Nancy Sajjadi	19
12	A Two-Allele Polymorphism in Protein C Inhibitor with Varying Frequencies in Different Ethnic Populations 1996 ·Thrombosis and Haemostasis ·(unknown),Judith S. Greengard,José A. Fernández,Bruno O. Villoutreix,John H. Griffin	8
13	Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V 1995 ·Thrombosis Research ·Judith S. Greengard,(unknown),Sophie Gandrille,John H. Griffin	13
14	Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding Sites 1995 ·Journal of Biological Chemistry ·C. Arnold Spek,Judith S. Greengard,John H. Griffin,Rogier M. Bertina,Pieter H. Reitsma	40
15	Activated Protein C Resistance: Molecular Mechanisms 1995 ·Thrombosis and Haemostasis ·John H. Griffin,Mary J. Heeb,Yumi Kojima,José A. Fernández,Kazutoshi Kojima,Tilman M. Hackeng,Judith S. Greengard	69
16	Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen 1994 ·Protein Science ·Cindy L. Fisher,Judith S. Greengard,John H. Griffin	39
17	Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three‐dimensional molecular modelling of mutations of the protease domain 1994 ·Proteins Structure Function and Bioinformatics ·Judith S. Greengard,Cindy L. Fisher,Bruno O. Villoutreix,John H. Griffin	34
18	Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V 1994 ·New England Journal of Medicine ·Judith S. Greengard,Sabine Eichinger,John H. Griffin,Kenneth A. Bauer	100
19	Possible Structural Implications of 20 Mutations in the Protein C Protease Domain 1994 ·Thrombosis and Haemostasis ·Judith S. Greengard,John H. Griffin,Cindy L. Fisher	4
20	Protein S, an Antithrombotic Factor, Is Synthesized and Released by Neural Tumor Cells 1993 ·Journal of Neurochemistry ·Donald J. Phillips,Judith S. Greengard,José A. Fernández,(unknown),B. L. Evatt,John H. Griffin,W. Craig Hooper	21

About Judith S. Greengard

Judith S. Greengard is a scholar working on Hematology, Genetics and Ophthalmology, having authored 26 papers that have together received 976 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Virus-based gene therapy research (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). The work is most often cited by research in Hematology (497 citations), Genetics (302 citations) and Internal Medicine (102 citations). Judith S. Greengard has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include John H. Griffin, Kenneth A. Bauer, Mary J. Heeb, Sabine Eichinger, Lindsey A. Miles, Cindy L. Fisher, Jonathan B. Rosenberg, Robert R. Montgomery, Claire M. Gelfman and Mehdi Gasmi. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact